Evidence map›Paper›PMID 31564197›Full record

ReviewCell cycle (Georgetown, Tex.)2019

The TCL1 function revisited focusing on metabolic requirements of stemness.

Maria Teresa Fiorenza, Alessandro Rava

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Maria Teresa FiorenzaDepartment of Psychology, Division of Neuroscience and "Daniel Bovet" Neurobiology Research Center, Sapienza University of Rome , Rome , Italy.ORCID https://orcid.org/0000-0002-5079-4019
Alessandro RavaDepartment of Psychology, Division of Neuroscience and "Daniel Bovet" Neurobiology Research Center, Sapienza University of Rome , Rome , Italy.
Fondazione Santa Lucia · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncogenic ability of the T-cell leukemia/lymphoma 1 gene, TCL1, has captured the attention in the field of prolymphocytic T-cell and B-cell chronic leukemias for more than two decades. However, the finding that TCL1 is also expressed in totipotent cells of the mouse preimplantation embryos and that it is among the 10 genes, including the transcription factors

Indexed as

AnimalsCell ProliferationCellular ReprogrammingEmbryonic DevelopmentEmbryonic Stem CellsEnergy MetabolismGlycolysisHumansInduced Pluripotent Stem CellsMiceOxidative PhosphorylationProto-Oncogene ProteinsProto-Oncogene Proteins c-aktTranscription FactorsProto-Oncogene ProteinsProto-Oncogene Proteins c-aktTCL1A protein, humanTcl1 protein, mouseTranscription Factorscell proliferation/differentiationEmbryonic totipotent/pluripotent stem cellsenergy metabolism shift

Identifiers

PMID31564197
PMCPMC6816351
OpenAlexW2977465300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.